Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Lycanbull Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1825866616254480384.png) Lycanbull [@Lycanbull](/creator/twitter/Lycanbull) on x 4956 followers
Created: 2025-07-17 12:02:12 UTC

$JNJ Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer


![](https://pbs.twimg.com/card_img/1945816297045999616/dAyObFkj?format=jpg&name=800x419)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945816300934009172/c:line.svg)

**Related Topics**
[$jnj](/topic/$jnj)
[johnson johnson](/topic/johnson-johnson)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/Lycanbull/status/1945816300934009172)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Lycanbull Avatar Lycanbull @Lycanbull on x 4956 followers Created: 2025-07-17 12:02:12 UTC

$JNJ Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer

XXX engagements

Engagements Line Chart

Related Topics $jnj johnson johnson stocks healthcare

Post Link

post/tweet::1945816300934009172
/post/tweet::1945816300934009172